Assyro AI

Orange Book product · Brand (NDA)

ZAVZPRET

ZAVEGEPANT HYDROCHLORIDE

Brand (NDA)NDA 216386RX PFIZER

At a glance

Mar 09, 2023

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 09, 2023

    3 yr 4 mo ago

  2. Today

  3. Exclusivity ends · NCE

    New chemical entity exclusivity (5 years)

    Mar 09, 2028

    in 1 yr 9 mo

  4. Patent 8481546 expires

    Listed drug substance patent expiration.

    Jun 26, 2034

    in 8 yr 2 mo

Pharmaceutical detail

Active ingredient

ZAVEGEPANT HYDROCHLORIDE

Strength

EQ 10MG BASE/SPRAY

Dosage form

SPRAY, METERED

Route

NASAL

TE code

Not listed

Application

NDA 216386

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (1)

  • NCENew chemical entity exclusivity (5 years)

    Mar 09, 2028

    in 1 yr 9 mo

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8481546Jun 26, 2034in 8 yr 2 mo
SubstanceProductU-3555
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.